Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Myelofibrosis Drug Development through the Decade: Novel JAK Inhibitors

Ali Younas Khan, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Awais Ijaz, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Hafiz Muhammad Fazeel, MD, Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Asad Fraz, MD, Muhammad Jahanzeb Khalil, MD, Jemin Aby Jose, MD, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5477.

https://doi.org/10.1182/blood-2018-99-115408

Published: 2018

Journal Articles

Efficacy and Safety of Daratumumab Based Regimens for Multiple Myeloma: A Systematic Review and Meta-Analysis

Muhammad Abu Zar, MD, Ahmad Kamal, MD, Ali Younas Khan, MD, Saad Ullah Malik, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Ceren Durer, MD, Seren Durer, MD, Insija Ilyas Selene, MBBS, Anum Qureshi, Jemin Aby Jose, MD, Hafiz Muhammad Fazeel, MD, Zunairah Shah, MBBS, Muhammad Adil Rehman, MBBS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 3292.

https://doi.org/10.1182/blood-2018-99-110580

Published: 2018

Journal Articles

Reduced-Intensity Conditioning Versus Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis of Randomized Trials

Ahmad Kamal, MD, Muhammad Abu Zar, MD, Hafiz Muhammad Fazeel, MD, Seren Durer, MD, Ceren Durer, MD, Syed Shabee Hassan, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Faiqa Ijaz, MBBS, Shehroz Aslam, MD, Faiz Anwer, MD, Mehdi Hamadani, MD

Blood (2018) 132 (Supplement 1): 5770.

https://doi.org/10.1182/blood-2018-99-114452

Published: 2018

Journal Articles

Diagnostic and Prognostic Role of Fecal Calprotectin As a Biomarker for Gastrointestinal Graft Versus Host Disease: A Systematic Review of Literature

Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Ali Younas Khan, MD, Anum Qureshi, Muhammad Abu Zar, MD, Ceren Durer, MD, Seren Durer, MD, Ahmad Kamal, MD, Insija Ilyas Selene, MBBS, Jemin Aby Jose, MD, Muhammad Jahanzeb Khalil, MD, Hafiz Muhammad Fazeel, MD, Muhammad Usman, MD, Awais Ijaz, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5725.

https://doi.org/10.1182/blood-2018-99-109857

Published: 2018

Journal Articles

Concomitant Use of Blinatumomab and Donor Lymphocyte Infusion for Post-Transplant Relapsed CD19 Positive Acute Lymphoblastic Leukemia: Systematic Review

Ceren Durer, MD, Seren Durer, MD, Madeeha Shafqat, Zunairah Shah, MBBS, Maryam Sadiq, MBBS, Muhammad Asad Fraz, MD, Malik Qistas Ahmad, MD MBBS, Hafiz Muhammad Fazeel, MD, Sharoon Samuel, MBBS, Mustafa Nadeem Malik, MD, Midhat Lakhani, MD, Chaudhry Saad Sohail, MD, Anum Qureshi, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5742.

https://doi.org/10.1182/blood-2018-99-109998

Published: 2018

Journal Articles

Presentation Patterns and Management Strategies for Central Nervous System Involvement in Multiple Myeloma: A Systematic Review of Literature

Jemin Aby Jose, MD, Insija Ilyas Selene, MBBS, Mustafa Nadeem Malik, MD, Anum Qureshi, Abdul Rafae, MD, Hafiz Muhammad Fazeel, MD, Muhammad Abu Zar, MD, Ahmad Kamal, MD, Saad Ullah Malik, MD, Ceren Durer, MD, Seren Durer, MD, Faiza Jamil, MD, Madeeha Shafqat, Muhammad Usman, MD, Giyth Mithim Mahdi, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1951.

https://doi.org/10.1182/blood-2018-99-109923

Published: 2018

Journal Articles

Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases

Hafiz Muhammad Fazeel, MD, Muhammad Abu Zar, MD, Saad Ullah Malik, MD, Ahmad Kamal, MD, Mustafa Nadeem Malik, MD, Syed Shabee Hassan, MD, Syeda Sabeeka Batool, MD, Ceren Durer, MD, Seren Durer, MD, Shehroz Aslam, MD, Madeeha Shafqat, Faiqa Ijaz, MBBS, Faiz Anwer, MD, Shahrukh K. Hashmi, MDMPH

Blood (2018) 132 (Supplement 1): 2194.

https://doi.org/10.1182/blood-2018-99-114511

Published: 2018

Journal Articles

Emerging Clinical Concepts for Personalized Therapy in Multiple Myeloma; Systemtic Review

Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Azka Latif, MD, Vikas Kapoor, MD, Faisal Akbar, MD, Ali McBride, PharmD,MS, Ahmad Iftikhar, MD, Pavan Tenneti, MD, Adeela Mushtaq, MD, Raahem Nayab Zafar, BS, Hafiz Muhammad Fazeel, MD, Syeda Sabeeka Batool, MBBS, Zabih Warraich, MD, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5411.

https://doi.org/10.1182/blood.V130.Suppl_1.5411.5411

Published: 2017

NARROW

Myelofibrosis Drug Development through the Decade: Novel JAK Inhibitors

Efficacy and Safety of Daratumumab Based Regimens for Multiple Myeloma: A Systematic Review and Meta-Analysis

Reduced-Intensity Conditioning Versus Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis of Randomized Trials

Diagnostic and Prognostic Role of Fecal Calprotectin As a Biomarker for Gastrointestinal Graft Versus Host Disease: A Systematic Review of Literature

Concomitant Use of Blinatumomab and Donor Lymphocyte Infusion for Post-Transplant Relapsed CD19 Positive Acute Lymphoblastic Leukemia: Systematic Review

Presentation Patterns and Management Strategies for Central Nervous System Involvement in Multiple Myeloma: A Systematic Review of Literature

Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases

Emerging Clinical Concepts for Personalized Therapy in Multiple Myeloma; Systemtic Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only